Amgen CEO Robert Bradway was featured in Forbes Magazine on July 7 to discuss COVID-19 clinical trials. The article, “Amgen CEO is ‘optimistic’ about COVID-19 clinical trials” by Aaron Pressman, says that the company is testing several drugs in an attempt to relieve symptoms of COVID-19. Amgen is a member of Bio Nebraska.